{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:07:29Z","timestamp":1694635649526},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T00:00:00Z","timestamp":1240012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00262-009-0707-6","type":"journal-article","created":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T21:53:13Z","timestamp":1240005193000},"page":"2003-2010","source":"Crossref","is-referenced-by-count":5,"title":["Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia"],"prefix":"10.1007","volume":"58","author":[{"given":"Nelson R.","family":"Tirone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethanea C.","family":"Peghini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina M.","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie F. C.","family":"Murta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia A.","family":"Michelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,18]]},"reference":[{"key":"707_CR1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801","journal-title":"Cell"},{"key":"707_CR2","first-page":"2865","volume":"15","author":"I Arany","year":"1995","unstructured":"Arany I, Goel A, Tyring SK (1995) Interferon response depends on viral transcription in human papillomavirus-containing lesions. Anticancer Res 15:2865\u20132869","journal-title":"Anticancer Res"},{"issue":"12","key":"707_CR3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2008","unstructured":"Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR (2008) Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6(12):975\u2013990","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"707_CR4","first-page":"283","volume":"57","author":"V Chieux","year":"1999","unstructured":"Chieux V, Hober D, Chehadeh W, Wattr P (1999) Anti-viral proteins: from interferon alpha to its receptor. Ann Biol Clin 57(3):283\u2013290","journal-title":"Ann Biol Clin"},{"key":"707_CR5","first-page":"145","volume":"23","author":"M Cintorino","year":"2002","unstructured":"Cintorino M, Tripodi SA, Romagnoli R, Ietta F, Ricci MG, Paulesu L (2002) Interferons and their receptors in human papillomavirus lesions of the uterine cervix. Eur J Gynaecol Oncol 23:145\u2013150","journal-title":"Eur J Gynaecol Oncol"},{"key":"707_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1872-034X.2007.00007.x","volume":"37","author":"B Damdinsuren","year":"2007","unstructured":"Damdinsuren B, Nagano H, Wada H, Noda T, Natsag J, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Monden M (2007) Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells. Hepatol Res 37:77\u201383","journal-title":"Hepatol Res"},{"key":"707_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-3542(99)00018-2","volume":"42","author":"F Marco De","year":"1999","unstructured":"De Marco F, Manni V, Guaricci N, Muller A, Marcante ML (1999) Induction of apoptotic cell death by IFN beta on HPV-16 transformed human keratinocytes. Antiviral Res 42:109\u2013120","journal-title":"Antiviral Res"},{"key":"707_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopha.2006.08.002","volume":"60","author":"G Diop","year":"2006","unstructured":"Diop G, Hirtzig T, Do H, Coulonges C, Vasilescu A, Labib T, Spadoni JL, Therwath A, Lathrop M, Matsuda F, Zagury JF (2006) Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed Pharmacother 60:569\u2013577","journal-title":"Biomed Pharmacother"},{"key":"707_CR9","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1128\/JVI.73.7.6166-6170.1999","volume":"73","author":"T Doan","year":"1999","unstructured":"Doan T, Herd K, Street M, Bryson G, Fernando G, Lambert P, Tindle R (1999) Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. J Virol 73:6166\u20136170","journal-title":"J Virol"},{"key":"707_CR10","doi-asserted-by":"crossref","first-page":"47004","DOI":"10.1074\/jbc.M104316200","volume":"276","author":"E Dondi","year":"2001","unstructured":"Dondi E, Pattyn E, Lutfalla G, Ostade XV, Uz\u00e9 G, Pellegrini S, Tavernier J (2001) Down-modulation of type i interferon responses by receptor cross-competition for a shared JAK kinase. J Biol Chem 276:47004\u201347012","journal-title":"J Biol Chem"},{"key":"707_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.929","volume":"195","author":"AM El-Sherif","year":"2001","unstructured":"El-Sherif AM, Seth R, Tighe PJ, Jenkins D (2001) Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 195:179\u2013185","journal-title":"J Pathol"},{"issue":"1","key":"707_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ni1287","volume":"7","author":"JE Fenner","year":"2006","unstructured":"Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, Sheehan K, Hilton DJ, Alexander WS, Hertzog PJ (2006) Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 7(1):33\u201339","journal-title":"Nat Immunol"},{"key":"707_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mc.1036","volume":"31","author":"V Fontaine","year":"2001","unstructured":"Fontaine V, Van der Meijden E, Ter Schegget J (2001) Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression. Mol Carcinog 31:27\u201336","journal-title":"Mol Carcinog"},{"key":"707_CR14","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1073\/pnas.0602800103","volume":"103","author":"AJ Frodsham","year":"2006","unstructured":"Frodsham AJ, Zhang L, Dumpis U, Taib NA, Best S, Durham A, Hennig BJ, Hellier S, Knapp S, Wright M, Chiaramonte M, Bell JI, Graves M, Whittle HC, Thomas HC, Thursz MR, Hill AV (2006) Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci USA 103:9148\u20139153","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR15","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn S, Didcock L, Randall RE (2000) Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341\u20132364","journal-title":"J Gen Virol"},{"key":"707_CR16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biochi.2007.02.003","volume":"89","author":"AG Hovanessian","year":"2007","unstructured":"Hovanessian AG, Justesen J (2007) The human 2\u2032-5\u2032oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2\u2032-5\u2032 instead of 3\u2032-5\u2032 phosphodiester bond formation. Biochimie 89:779\u2013788","journal-title":"Biochimie"},{"key":"707_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs A, Lindenmann J (1957) Virus interference I. The interferon. Proc R Soc Lond B Biol Sci 147:258\u2013267","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"707_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197\u2013216","journal-title":"Annu Rev Immunol"},{"key":"707_CR19","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/JVI.67.6.3396-3403.1993","volume":"67","author":"MA Khan","year":"1993","unstructured":"Khan MA, Tolleson WH, Gangemi JD, Pirisi L (1993) Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons. J Virol 67:3396\u20133403","journal-title":"J Virol"},{"key":"707_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1359-6101(00)00023-X","volume":"12","author":"AE Koromilas","year":"2001","unstructured":"Koromilas AE, Li S, Matlashewski G (2001) Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev 12:157\u2013170","journal-title":"Cytokine Growth Factor Rev"},{"key":"707_CR21","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1038\/sj.onc.1202960","volume":"18","author":"S Li","year":"1999","unstructured":"Li S, Labrecque S, Gauzzi MC, Cuddihy AR, Wong AH, Pellegrini S, Matlashewski GJ, Koromilas AE (1999) The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727\u20135737","journal-title":"Oncogene"},{"key":"707_CR22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00535-005-1616-x","volume":"40","author":"K Matsumoto","year":"2005","unstructured":"Matsumoto K, Okano J, Murawaki Y (2005) Differential effects of interferon alpha-2b and beta on the signaling on pathways in human liver cancer cells. J Gastroenterol 40:722\u2013732","journal-title":"J Gastroenterol"},{"key":"707_CR23","first-page":"10","volume":"29","author":"MA Michelin","year":"2007","unstructured":"Michelin MA, Murta EFC (2007) Potential therapeutic vaccine strategies and relevance of immune system in uterine cervical cancer. Eur J Gynaecol Oncol 29:10\u201318","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"707_CR24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX DE, Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518\u2013527","journal-title":"N Engl J Med"},{"issue":"1","key":"707_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0100-72031998000100006","volume":"20","author":"EFC Murta","year":"1998","unstructured":"Murta EFC (1998) Influ\u00eancia da idade materna, do per\u00edodo gestacional e do n\u00famero de gesta\u00e7\u00f5es na infec\u00e7\u00e3o pelo papilomav\u00edrus humano. Rev Bras Ginecol Obstet 20(1):33\u201335","journal-title":"Rev Bras Ginecol Obstet"},{"key":"707_CR26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0006-291X(90)92161-R","volume":"170","author":"A Nawa","year":"1990","unstructured":"Nawa A, Nishiyama Y, Yamamoto N, Maeno K, Goto S, Tomoda Y (1990) Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon. Biochem Biophys Res Commun 170:793\u2013799","journal-title":"Biochem Biophys Res Commun"},{"key":"707_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","volume":"77","author":"D Novick","year":"1994","unstructured":"Novick D, Cohen B, Rubinstein M (1994) The human interferon alpha\/beta receptor: characterization and molecular cloning. Cell 77:391\u2013400","journal-title":"Cell"},{"key":"707_CR28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bjc.6602742","volume":"93","author":"H Ota","year":"2005","unstructured":"Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Nakamura M, Damdinsuren B, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M (2005) Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer 93:557\u2013564","journal-title":"Br J Cancer"},{"issue":"19","key":"707_CR29","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1128\/JVI.78.19.10516-10524.2004","volume":"78","author":"D Pannetier","year":"2004","unstructured":"Pannetier D, Faure C, Georges-Courbot MC, Deubel V, Baize S (2004) Human macrophages, but not dendritic cells, are activated and produce alpha\/beta interferons in response to Mopeia virus infection. J Virol 78(19):10516\u201310524","journal-title":"J Virol"},{"key":"707_CR30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1006\/bbrc.1995.2405","volume":"214","author":"CC Pao","year":"1995","unstructured":"Pao CC, Lin CY, Yao DS, Tseng CJ (1995) Differential expression of cytokine genes in cervical cancer tissues. Biochem Biophys Res Commun 214:1146\u20131151","journal-title":"Biochem Biophys Res Commun"},{"key":"707_CR31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/jir.1995.15.495","volume":"15","author":"SE Perea","year":"1995","unstructured":"Perea SE, Lopez-Ocejo O, Garcia-Milian R, Arana MJ (1995) Interferon-alpha elicits downregulation of human papillomavirus 18 mRNA in HeLa cells by selective repression of endogenous viral transcription. J Interferon Cytokine Res 15:495\u2013501","journal-title":"J Interferon Cytokine Res"},{"key":"707_CR32","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1016\/S0021-9258(17)32371-2","volume":"269","author":"LC Platanias","year":"1994","unstructured":"Platanias LC, Uddin S, Colamonici OR (1994) Tyrosine phosphorylation of the D and E subunits of the type I interferon receptor. J Biol Chem 269:17761\u201317764","journal-title":"J Biol Chem"},{"issue":"4","key":"707_CR33","first-page":"695","volume":"28","author":"RM Richart","year":"1968","unstructured":"Richart RM, Shingleton HM, Wiener J, Spiro D (1968) Human cervical intraepithelial neoplasia: fine structure of dysplasia and carcinoma in situ. Cancer Res 28(4):695\u2013706","journal-title":"Cancer Res"},{"key":"707_CR34","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","volume":"12","author":"LV Ronco","year":"1998","unstructured":"Ronco LV, Karpova AY, Vidal M, Howley PM (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061\u20132072","journal-title":"Genes Dev"},{"key":"707_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2004.03.056","volume":"30","author":"T Saito","year":"2004","unstructured":"Saito T, Ji G, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito JI, Watanabe H, Saito K, Togashi H, Ishii K, Matsuura T, Inageda K, Muramatsu M, Kawata S (2004) Genetic variations in humans associated with differences in the course of hepatitis C. Biochem Biophys Res Commun 30:335\u2013341","journal-title":"Biochem Biophys Res Commun"},{"key":"707_CR36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778\u2013809","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"707_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2007.11.006","volume":"108","author":"SH Song","year":"2008","unstructured":"Song SH, Lee JK, Lee NW, Saw HS, Kang JS, Lee KW (2008) Interfeon-\u03b3: a possible prognostic marker for clearance of high-risk human papilomavirus (HPV). Gynecol Oncol 108(3):543\u2013548","journal-title":"Gynecol Oncol"},{"key":"707_CR38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227\u2013264","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"707_CR39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","volume":"23","author":"MH Stoler","year":"1992","unstructured":"Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 23(2):117\u2013128","journal-title":"Hum Pathol"},{"key":"707_CR40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1081-1206(10)62005-4","volume":"88","author":"S Uthaisangsook","year":"2002","unstructured":"Uthaisangsook S, Day NK, Bahna SL, Good RA, Haraguchi S (2002) Innate immunity and its role against infections. Ann Allergy Asthma Immunol 88:253\u2013264","journal-title":"Ann Allergy Asthma Immunol"},{"key":"707_CR41","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1073\/pnas.89.10.4774","volume":"89","author":"G Uze","year":"1992","unstructured":"Uze G, Lutfalla G, Bandu MT, Proudhon D, Moogensen KE (1992) Behaviour of a cloned murine interferon alpha\/beta receptor expressed in homospecific or heterospecific background. Proc Natl Acad Sci USA 89:4774\u20134778","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"707_CR42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mu\u00f1oz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319","journal-title":"J Pathol"},{"key":"707_CR43","first-page":"456","volume":"52","author":"CD Woodworth","year":"1992","unstructured":"Woodworth CD, Lichti U, Simpson S, Evans CH, Di Paolo JA (1992) Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res 52:456\u2013463","journal-title":"Cancer Res"},{"issue":"7","key":"707_CR44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730\u2013737","journal-title":"Nat Immunol"},{"key":"707_CR45","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.178.8.4832","volume":"178","author":"JM Zimmerer","year":"2007","unstructured":"Zimmerer JM, Lesinski GB, Kondadasula SV, Karpa VI, Lehman A, Raychaudhury A, Becknell B, Carson WE (2007) IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol 178:4832\u20134845","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-009-0707-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0707-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T07:17:11Z","timestamp":1633331831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-009-0707-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,18]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s00262-009-0707-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,18]]}}}